Unknown

Dataset Information

0

Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer.


ABSTRACT: Adipose tissue dysregulation, a hallmark of obesity, contributes to a chronic state of low-grade inflammation and is associated with increased risk and progression of several breast cancer subtypes, including claudin-low breast tumors. Unfortunately, mechanistic targets for breaking the links between obesity-associated adipose tissue dysfunction, inflammation, and claudin-low breast cancer growth have not been elucidated. Ovariectomized female C57BL/6 mice were randomized (n?=?15/group) to receive a control diet, a diet-induced obesity (DIO) diet, or a DIO?+?resveratrol (0.5% wt/wt) diet. Mice consumed these diets ad libitum throughout study and after 6 weeks were orthotopically injected with M-Wnt murine mammary tumor cells, a model of estrogen receptor (ER)-negative claudin-low breast cancer. Compared with controls, DIO mice displayed adipose dysregulation and metabolic perturbations including increased mammary adipocyte size, cyclooxygenase-2 (COX-2) expression, inflammatory eicosanoid levels, macrophage infiltration, and prevalence of crown-like structures (CLS). DIO mice (relative to controls) also had increased systemic inflammatory cytokines and decreased adipocyte expression of peroxisome proliferator-activated receptor gamma (PPAR?) and other adipogenesis-regulating genes. Supplementing the DIO diet with resveratrol prevented obesity-associated increases in mammary tumor growth, mammary adipocyte hypertrophy, COX-2 expression, macrophage infiltration, CLS prevalence, and serum cytokines. Resveratrol also offset the obesity-associated downregulation of adipocyte PPAR? and other adipogenesis genes in DIO mice. Our findings suggest that resveratrol may inhibit obesity-associated inflammation and claudin-low breast cancer growth by inhibiting adipocyte hypertrophy and associated adipose tissue dysregulation that typically accompanies obesity.

SUBMITTER: Rossi EL 

PROVIDER: S-EPMC6053655 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer.

Rossi Emily L EL   Rossi Emily L EL   Khatib Subreen A SA   Doerstling Steven S SS   Bowers Laura W LW   Pruski Melissa M   Ford Nikki A NA   Glickman Randolph D RD   Niu Mengmeng M   Yang Peiying P   Cui Zhengrong Z   DiGiovanni John J   Hursting Stephen D SD  

Molecular carcinogenesis 20171201 3


Adipose tissue dysregulation, a hallmark of obesity, contributes to a chronic state of low-grade inflammation and is associated with increased risk and progression of several breast cancer subtypes, including claudin-low breast tumors. Unfortunately, mechanistic targets for breaking the links between obesity-associated adipose tissue dysfunction, inflammation, and claudin-low breast cancer growth have not been elucidated. Ovariectomized female C57BL/6 mice were randomized (n = 15/group) to recei  ...[more]

Similar Datasets

| S-EPMC7118089 | biostudies-literature
| S-EPMC5024781 | biostudies-literature
| S-EPMC4375084 | biostudies-literature
| S-EPMC7506791 | biostudies-literature
| S-EPMC4789163 | biostudies-literature
| S-EPMC4551605 | biostudies-literature
| S-EPMC9218513 | biostudies-literature
| S-EPMC2649017 | biostudies-literature
| S-EPMC3964504 | biostudies-literature
| S-EPMC8381800 | biostudies-literature